Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AMNEAL

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 27
  • 0 comments

FDA approve PROCHLORPERAZINE MALEATE

Comment Full text

ABBVIE

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 29
  • 0 comments

FDA approve ATOGEPANT

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 28
  • 0 comments

FDA approve ROFLUMILAST

Comment Full text

DAIICHI SANKYO INC

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 28
  • 0 comments

FDA approve PEXIDARTINIB HYDROCHLORIDE

Comment Full text

APOTEX

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 29
  • 0 comments

FDA approve MOXIFLOXACIN HYDROCHLORIDE

Comment Full text

TAKEDA PHARMS USA

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 27
  • 0 comments

FDA approve FEBUXOSTAT

Comment Full text

GLAXOSMITHKLINE CONS

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 29
  • 0 comments

FDA approve ACETAMINOPHEN; ASPIRIN; CAFFEINE

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 26
  • 0 comments

FDA approve NITROFURANTOIN

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 28
  • 0 comments

FDA approve ISOPROTERENOL HYDROCHLORIDE

Comment Full text

ASPIRO

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 28
  • 0 comments

FDA approve FOSAPREPITANT DIMEGLUMINE

Comment Full text
  • Previous
  • 839
  • 840
  • 841
  • 842
  • 843
  • Next

Search

News categories

  • Technical Exchange News(12129)
  • Event(5779)
  • SEC News(257776)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(152334)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin